Special Issue "Responsible Use of Opioids"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 December 2020).
Interests: hospital pharmacy practice; medication safety; high-risk medicines; pain; opioids; responsible prescribing; health technology; informatics
Opioids are an important cornerstone for pain management, primarily in acute and cancer pain. However, opioids are recognised as high-risk medicines, and their efficacy must be weighed against significant potential harms. Increasing use of opioids has resulted in greater opioid-related harms - including opioid use disorder and opioid toxicity - leading to more hospitalizations and deaths within our communities. Unfortunately, misinformation regarding opioids still exists amongst people who use opioids and health care professionals, contributing to such patient safety concerns. Large variation in the use of opioids has also been observed globally, with some countries using the majority of opioids and other countries using very little. This large variation in opioid prescribing is further compounded by regulatory differences for opioids, actual availability, stigma surrounding addiction and the use of technology to monitor opioid supply and use. The pharmacy professions is well positioned and holds the expertise to play a key role in optimizing safe and appropriate opioid use.
We invite you and your colleagues to submit articles for this Special Issue on Responsible Use of Opioids. We welcome research studies and reviews relating to opioid use in pharmacy and clinical practice, health professional education regarding pain management and opioid use, relevant theoretical and methodological reflections, as well as commentaries discussing tendencies and challenges in using opioids responsibly.
Dr. Jonathan Penm
Dr. Jacinta Johnson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Harm minimisation
- Medication safety